James E. Levine, Chief Financial Officer at Cardiff Oncology, Inc. (CRDF), bought 30,000 shares at $6.38 ($194K) on 2021-09-10, disclosed to the SEC on 2021-09-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.32 | 5,000 | $32K | 16.3% |
| 2 | $6.35 | 5,000 | $32K | 16.4% |
| 3 | $6.38 | 10,000 | $64K | 32.9% |
| 4 | $6.62 | 5,000 | $33K | 17.1% |
| 5 | $6.75 | 5,000 | $34K | 17.4% |
| Total | $6.47 avg | 30,000 |
| $194K |
| 100% |
| Filing → |
| CDTX | BUY | 2020-11-12 | $201K | — | Filing → |
| CDTX | BUY | 2020-03-23 | $57K | — | Filing → |
| VRNM | BUY | 2012-05-16 | $18K | — | Filing → |